AMCAP
LIVE

Serial Number

79434997

Owner

ANEMOCYTE S.R.L.

Filing Date

Aug 4, 2025

Add to watchlist:

No watchlists yet
View on USPTO

AMCAP Trademark

Serial Number: 79434997

AMCAP is a trademark filed by ANEMOCYTE S.R.L. on August 4, 2025. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

ANEMOCYTE S.R.L. (5 trademarks)

Via R. Lepetit, 34

Entity Type: 16

Trademark Details

Filing Date

August 4, 2025

Registration Date

Not Registered

Goods & Services

Research and development of vaccines and nucleic acid-based medicines; scientific and technological services; research services in the medical and pharmaceutical fields; development of pharmaceutical preparations and medicines; development of pharmaceutical reagents and medicines; providing information and data relating to medical and veterinary research and development; medical laboratories; design and development of hardware and software; research and development in the biochemical and nucleic acid fields; research and development services in the field of microorganisms and cells; research and development services in the field of diagnostic preparations; research and development in the pharmaceutical and biotechnological sector; research and development services for the pharmaceutical industry; scientific research in the biological field; research on medicines; research on reagents; medical research laboratory services; research services for the development of new pharmaceutical products and advanced therapies; development of biological drugs and advanced therapies; biological and chemical analysis in the medical and pharmaceutical fields.

Pharmaceutical drugs; medicines; chemical preparations for pharmaceutical purposes; biological preparations for medical purposes; chemico-pharmaceutical preparations; biological reagents for medical purposes; vaccines; nucleic acid-based pharmaceutical and veterinary products; food and dietary substances for medical or veterinary use; therapeutic antibodies; dietary supplements and preparations; pharmaceutical and natural medicines; nucleic acid-based preparations; cell-based preparations; tissue-based preparations; biological preparations; biological preparations for medical and pharmaceutical use; diagnostic preparations; engineered biological tissues for medical purposes; sanitary preparations for medical purposes; advanced therapy medicinal products; personalized medicine products; regenerative medicine products; somatic cell therapy products; gene therapy products; recombinant human protein being biochemical preparations and nucleic acid sequences for medical use.

Filing History

REFUSAL PROCESSED BY IB
Feb 26, 2026 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Feb 6, 2026 RFCS
REFUSAL PROCESSED BY MPU
Feb 5, 2026 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jan 10, 2026 RFCR
NON-FINAL ACTION WRITTEN
Jan 9, 2026 CNRT
ASSIGNED TO EXAMINER
Dec 17, 2025 DOCK
APPLICATION FILING RECEIPT MAILED
Oct 21, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 21, 2025 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Oct 16, 2025 REPR